19 h. ago Daily fat busting PILL made by Mounjaro maker dramatically slashes weight AND blood sugar levels, latest trial shows

The once-a-day pill belongs to class of medications called GLP-1 agonists, like Mounjaro, which suppress appetite and make users feel fuller for longer.

Events

3 d. ago Root canal treatment could significantly lower blood sugar levels, study suggests

Dentists also saw improvements in patients’ cholesterol and fatty acid levels, both associated with heart healthIf a looming root canal treatment is putting a dampener on the week, take heart: having the procedure can drive health benefits that are felt throughout the body, according to research.Patients who were successfully treated for root canal infections saw their blood sugar levels fall significantly over two years, suggesting that ridding the body of the problematic bacteria could help protect against type 2 diabetes. Continue reading...

Events

1 week ago Drivers with health condition affected by major new DVLA rule change

The DVLA has said that from today, bus, coach and lorry drivers with diabetes will be able to monitor their glucose (sugar) levels using modern technology

Politics

2 w. ago Ozempic maker struggles as it loses ground to rivals in weight

Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli LillyThe maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments.Novo Nordisk’s chief executive, Mike Doustdar, who took the reins in August, said the reduced guidance was because of “the lower growth expectations for our GLP-1 treatments”. Continue reading...

Politics

2 w. ago Ozempic maker Novo Nordisk cuts sales and profit forecasts again

Downgrade comes as Danish company continues to lose ground to Mounjaro firm Eli Lilly in weight-loss drug marketThe maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments.Novo Nordisk’s chief executive, Mike Doustdar, who took the reins in August, said the reduced guidance was because of “the lower growth expectations for our GLP-1 treatments”. Continue reading...

Economics

4 w. ago BBC doctor warns anyone taking amitriptyline, nortriptyline, sertraline, fluoxetine

Research showed antidepressants making changes in heart rate, blood pressure and weight

Events

4 w. ago Antidepressant alert: key update for anyone taking sertraline, amitriptyline, citalopram and maprotiline

Research shows that antidepressants can affect heart rate, blood pressure, and weight, with some patients reportedly gaining nearly 5lbs almost 'instantly'

Events

last month New alert to anyone taking sertraline, amitriptyline, citalopram or maprotiline

Research has linked antidepressants to changes in heart rate, blood pressure and weight - with some 'instantly' gaining almost 5lbs

Events

last month Sertraline and citalopram linked to change in weight and blood pressure

The antidepressants, alongside others like amitriptyline and maprotiline, have been found to change heart rate and cause some people to gain weight rapidly

Events